Cite

MLA Citation

    J Kuon et al.. “1508TiPDurvalumab in frail and elder patients with stage four NSCLC: The DURATION trial.” Annals of oncology, vol. 29, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100095517591.0x000034
  
Back to record